Tubulis has completed a Series C, securing €308m ($361m) to be directed towards advancing clinical development of its ADC ...

A consortium led by Nordic Capital and Permira has raised its bid, though certain shareholder stances remain firm.

The WHO calls for increased policy focus on neurological disorders like Alzheimer’s disease, an indication that has seen ...

Goldman Sachs has secured the top spot as the leading financial adviser in mergers and acquisitions (M&A) based on deal value ...

Kirkland & Ellis has secured the foremost position as a legal adviser in the mergers and acquisitions (M&A) sector in terms ...

Pfizer's Tukysa could become the first update to the maintenance regimen for HER2-positive breast cancer in over a decade if ...

Nabla Bio has entered a new multi-year research collaboration with Takeda to advance AI-driven design of protein therapeutics ...

BioCryst Pharmaceuticals has signed a definitive agreement to buy Astria Therapeutics with a mix of cash and stock ...

J&J’s surprise orthopaedic separation announcement arrived hot on the heels of positive Q3 financial results for the company.

Just a year after emerging from stealth with a nearly half a billion dollars, Kailera Therapeutics has reached another ...